Literature DB >> 22137697

Empirical treatment of low-level leukocytospermia with doxycycline in male infertility patients.

Alaa Hamada1, Ashok Agarwal, Reecha Sharma, Dan B French, Ahmed Ragheb, Edmund S Sabanegh.   

Abstract

OBJECTIVE: To design a retrospective study in which infertile men with a seminal leukocyte count of 0.2-1 × 10(6) white blood cells [WBC]/mL were given doxycycline to examine the potential benefits of the treatment on the improvement of semen parameters and natural pregnancy outcomes. It has been reported that even low-level leukocytospermia (0.2-1.0 × 10(6) WBC/mL) could be harmful to male reproductive function and achievement of pregnancy.
METHODS: The records of 223 patients were reviewed and 61 patients were identified with a leukocyte count of 0.2-1.0 × 10(6) WBC/mL. Of the 61 patients, 27 presented before 2006 and were not routinely treated for this level of leukocytospermia. These patients were our historic control population. Since 2006, 34 patients met these criteria and received empirical antibiotic therapy (treatment group).
RESULTS: The treatment of low-level leukocytospermia with doxycycline did not show statistically significant differences in the semen parameters among the treated patients. Although the therapy did not alter the semen parameters, low-level leukocytospermia resolved in 56% of the treatment group, well above the spontaneous resolution rate of 25% observed in historic controls. The natural pregnancy rate among the treatment group (15 of 32 [47%]) was significantly greater than that among the controls (5 of 25 [20%]). The odds ratio for pregnancy outcome was 3.7 (95% confidence interval 1.1-11.7; P = .04).
CONCLUSION: Low-level leukocytospermia might have deleterious effects on male fertility, and antibiotic therapy for such a condition might improve the natural pregnancy rate among infertile couples.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22137697     DOI: 10.1016/j.urology.2011.08.062

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Urogenital Infection as a Risk Factor for Male Infertility.

Authors:  Hans-Christian Schuppe; Adrian Pilatz; Hamid Hossain; Thorsten Diemer; Florian Wagenlehner; Wolfgang Weidner
Journal:  Dtsch Arztebl Int       Date:  2017-05-12       Impact factor: 5.594

Review 2.  Oxidative Stress and Idiopathic Male Infertility.

Authors:  Pallav Sengupta; Shubhadeep Roychoudhury; Monika Nath; Sulagna Dutta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Nonsurgical Management of Oligozoospermia.

Authors:  Jeremy T Choy; John K Amory
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

4.  Reactive oxygen species and sperm DNA damage in infertile men presenting with low level leukocytospermia.

Authors:  Ashok Agarwal; Aditi Mulgund; Saad Alshahrani; Mourad Assidi; Adel M Abuzenadah; Rakesh Sharma; Edmund Sabanegh
Journal:  Reprod Biol Endocrinol       Date:  2014-12-19       Impact factor: 5.211

5.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.

Authors:  Louise C Kenny; Douglas B Kell
Journal:  Front Med (Lausanne)       Date:  2018-01-04

6.  Ibuprofen does not have an adverse impact on semen parameters.

Authors:  Parviz K Kavoussi; Melissa S Gilkey; Caitlin Hunn; G Luke Machen; Shu-Hung Chen; J David Wininger; Keikhosrow M Kavoussi; Shahryar K Kavoussi
Journal:  J Assist Reprod Genet       Date:  2018-10-17       Impact factor: 3.412

Review 7.  Pyospermia: background and controversies.

Authors:  Danielle Velez; Samuel Ohlander; Craig Niederberger
Journal:  F S Rep       Date:  2021-01-11

Review 8.  Review of Guidelines for the Evaluation and Treatment of Leukocytospermia in Male Infertility.

Authors:  Robert J Brunner; Jonathan H Demeter; Puneet Sindhwani
Journal:  World J Mens Health       Date:  2018-12-31       Impact factor: 5.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.